Search Results - "Zier, S."

Refine Results
  1. 1

    Comparison of several approaches to the linear approximation of the yield condition and application to the robust design of plane frames for the case of uncertainty by Zier, S.

    Published in Computers & structures (01-11-2011)
    “…Since the yield condition for frame structures is non-linear, piecewise linear approximations are needed in order to apply linear optimization methods. Four…”
    Get full text
    Journal Article
  2. 2

    Surrogate decision makers' responses to physicians' predictions of medical futility by Zier, Lucas S, Burack, Jeffrey H, Micco, Guy, Chipman, Anne K, Frank, James A, White, Douglas B

    Published in Chest (01-07-2009)
    “…Although physicians sometimes use the futility rationale to limit the use of life-sustaining treatments, little is known about how surrogate decision makers…”
    Get more information
    Journal Article
  3. 3

    Successful Use of Pulmonary Vasodilators in Acute Chest Syndrome Complicated by Persistent Right Ventricular Failure by DesJardin, Jacqueline T., Zier, Lucas S.

    Published in Case reports in cardiology (01-01-2019)
    “…Pulmonary hypertension (PH) is a known consequence of sickle cell disease (SCD) and is associated with increased mortality and more frequent episodes of acute…”
    Get full text
    Journal Article
  4. 4

    Echocardiographic estimation of pulmonary vascular resistance in advanced lung disease by DesJardin, Jacqueline T., Svetlichnaya, Yana, Kolaitis, Nicholas A., Hays, Steven R., Kukreja, Jasleen, Schiller, Nelson B., Zier, Lucas S., Singer, Jonathan P., De Marco, Teresa

    Published in Pulmonary circulation (01-01-2023)
    “…Noninvasive assessment of pulmonary hemodynamics is often performed by echocardiographic estimation of the pulmonary artery systolic pressure (ePASP), despite…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A 6.4-Gb/s CMOS SerDes core with feed-forward and decision-feedback equalization by Beukema, T., Sorna, M., Selander, K., Zier, S., Ji, B.L., Murfet, P., Mason, J., Rhee, W., Ainspan, H., Parker, B., Beakes, M.

    Published in IEEE journal of solid-state circuits (01-12-2005)
    “…A 4.9-6.4-Gb/s two-level SerDes ASIC I/O core employing a four-tap feed-forward equalizer (FFE) in the transmitter and a five-tap decision-feedback equalizer…”
    Get full text
    Journal Article
  7. 7

    Surrogate Decision Makers' Interpretation of Prognostic Information: A Mixed-Methods Study by ZIER, Lucas S, SOTTILE, Peter D, YEON HONG, Seo, WEISSFIELD, Lisa A, WHITE, Douglas B

    Published in Annals of internal medicine (06-03-2012)
    “…Little is known about why surrogate decision makers for patients with advanced illness often have overly optimistic expectations about prognosis. To determine…”
    Get full text
    Journal Article
  8. 8

    Association Between Coronary Assessment in Heart Failure and Clinical Outcomes Within a Safety-Net Setting Using a Target Trial Emulation Observational Design by Durstenfeld, Matthew S, Thakkar, Anjali, Ma, Yifei, Zier, Lucas S, Davis, Jonathan D, Hsue, Priscilla Y

    “…Ischemic cardiomyopathy is the leading cause of heart failure (HF). Most patients do not undergo coronary assessment after HF diagnosis. There are no…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Heparin Does Not Regulate Circulating Human PCSK9 (Proprotein Convertase Subtilisin-Kexin Type 9) in a General Population—Brief Report by Xia, Vivian Q., Ong, Chui Mei, Zier, Lucas S., MacGregor, John S., Wu, Alan H.B., Chorba, John S.

    “…PCSK9 (proprotein convertase subtilisin-kexin type 9) chaperones the hepatic LDLR (low-density lipoprotein receptor) for lysosomal degradation, elevating serum…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Doubt and belief in physicians’ ability to prognosticate during critical illness: The perspective of surrogate decision makers by Zier, Lucas S, Burack, Jeffrey H, Micco, Guy, Chipman, Anne K, Frank, James A, Luce, John M, White, Douglas B

    Published in Critical care medicine (01-08-2008)
    “…OBJECTIVES:Although discussing a prognosis is a duty of physicians caring for critically ill patients, little is known about surrogate decision-makers’ beliefs…”
    Get full text
    Journal Article
  13. 13

    To close or not to close: contemporary indications for patent foramen ovale closure by Zier, Lucas S, Sievert, Horst, Mahadevan, Vaikom S

    Published in Expert review of cardiovascular therapy (01-11-2016)
    “…Patent foramen ovale (PFO) is a common congenital cardiac abnormality and that has been associated with several disease processes including transient ischemic…”
    Get more information
    Journal Article
  14. 14
  15. 15
  16. 16

    Abnormal signal transduction by T cells of mice with parental tumors is not seen in mice bearing IL-2-secreting tumors by Salvadori, S, Gansbacher, B, Pizzimenti, AM, Zier, KS

    Published in The Journal of immunology (1950) (01-12-1994)
    “…There is considerable evidence to demonstrate that immune function is abnormal in tumor-bearing mice, perhaps accounting, at least in part, for progressive…”
    Get full text
    Journal Article
  17. 17

    Generation of anti-allogeneic cytotoxic T lymphocytes depends upon a signal, not delivered by tumor cells, that can be provided in trans in the presence of exogenous interleukin-2 by ZIER, K. S, SALVADORI, S

    Published in Cancer Immunology, Immunotherapy (01-08-1999)
    “…We have reported that, while immune responses were generated initially against CMS5 tumor cells, they were lost with time. In the present work, we asked…”
    Get full text
    Journal Article
  18. 18

    Tumour cell vaccines that secrete interleukin-2 (IL-2) and interferonγ (IFN-γ) are recognised by T cells while resisting destruction by natural killer (NK) cells by Zier, K.S., Gansbacher, B.

    Published in European journal of cancer (1990) (01-07-1996)
    “…The inoculation into mice of genetically engineered tumour cells that secrete IL-2 or IFNγ results in rejection, while unmodified parental tumour cells grow…”
    Get full text
    Journal Article
  19. 19

    IL-2 gene therapy of solid tumors : an approach for the prevention of signal transduction defects in T cells by ZIER, K. S, GANSBACHER, B

    “…The identification of tumor-associated antigens has focused attention on the mechanisms that underlie the failure of T cells to destroy tumor cells. A deeper…”
    Get full text
    Journal Article
  20. 20